<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://gta-us.org/page-1075178/BlogPost/7015287/RSS" rel="self" type="application/rss+xml" />
    <title>Genetic Toxicology Association News</title>
    <link>https://gta-us.org/</link>
    <description>Genetic Toxicology Association blog posts</description>
    <dc:creator>Genetic Toxicology Association</dc:creator>
    <generator>Wild Apricot - membership management software and more</generator>
    <language>en</language>
    <pubDate>Mon, 06 Jul 2026 20:59:18 GMT</pubDate>
    <lastBuildDate>Mon, 06 Jul 2026 20:59:18 GMT</lastBuildDate>
    <item>
      <pubDate>Tue, 30 Jun 2026 16:05:11 GMT</pubDate>
      <title>Congratulations to Robert Heflich on receiving the 2026 Genetic Toxicology Association Excellence in Science Award!</title>
      <description>&lt;p&gt;&lt;font face="Ubuntu" style="font-size: 18px;"&gt;The 2026 ESA Scientific Achievement Award was presented to&amp;nbsp;&lt;strong style=""&gt;Dr. Robert H. Heflich&lt;/strong&gt;&amp;nbsp;in recognition of his outstanding contributions to&amp;nbsp;the field of&amp;nbsp;genetic toxicology. Throughout his distinguished career at the Food and Drug Administration’s National Center for Toxicological Research (NCTR), Dr. Heflich played&amp;nbsp;an important role&amp;nbsp;in transition from traditional, animal‑based testing approaches to innovative, human‑relevant in vitro systems.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face="Ubuntu" style="font-size: 18px;"&gt;During his tenure at NCTR, Dr. Heflich served as Director of the Division of Genetic and Molecular Toxicology, published more than 250 scientific papers, and played a leading role in developing sensitive mutation assays, including the human PIG‑A assay. His work also advanced 3‑D human airway and liver models and improved approaches for&amp;nbsp;translating in&amp;nbsp;vitro findings to human risk assessment. His leadership and scientific vision have had a lasting impact on regulatory toxicology and public health.&amp;nbsp;The GTA is proud to recognize Dr. Heflich’s legacy of innovation, mentorship, and service with the 2026 Excellence in Science Award. Congratulations, Dr. Heflich!&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font face="Ubuntu" style="font-size: 18px;"&gt;&lt;img src="https://gta-us.org/resources/Pictures/Heflich%20Tall.JPG" alt="" title="" border="0" width="302.5" height="335"&gt;&lt;br&gt;&lt;/font&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13648315</link>
      <guid>https://gta-us.org/News/13648315</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Wed, 08 Apr 2026 15:07:51 GMT</pubDate>
      <title>Webinar recording now available – Everything you wanted to know about the in vivo comet assay but were afraid to ask!</title>
      <description>&lt;p data-olk-copy-source="MessageBody"&gt;&lt;font color="#242424" face="Ubuntu" style="font-size: 18px;"&gt;On April 7, 2026, the GTA hosted its second webinar, Everything you wanted to know about the in vivo comet assay but were afraid to ask! Speakers Marie Vasquez (Helix3 Inc.) and&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font color="#242424" face="Ubuntu" style="font-size: 18px;"&gt;Wei Ding,&lt;font color="#616161"&gt;&amp;nbsp;(&lt;/font&gt;US FDA/CDER) provided a deep dive into the comet assay including methodology and data interpretation, the role of the assay in regulatory genotoxicity assessment and blind case studies.&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font color="#242424" face="Ubuntu" style="font-size: 18px;"&gt;&lt;strong style=""&gt;GTA members can view the recording by logging into the Member Portal.&lt;/strong&gt;&lt;/font&gt;&lt;/p&gt;

&lt;p&gt;&lt;font color="#242424" face="Calibri, sans-serif" style="font-size: 15px;"&gt;&lt;strong&gt;&lt;img src="https://gta-us.org/resources/Pictures/News%20Images/2026-04%20GTA%20Webinar%20In%20Vivo.png" alt="" title="" border="0" width="300" height="300" style=""&gt;&lt;/strong&gt;&lt;/font&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13618308</link>
      <guid>https://gta-us.org/News/13618308</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Thu, 30 Oct 2025 14:33:00 GMT</pubDate>
      <title>Congratulations to Dr. David Kirkland on receiving the 2025 Genetic Toxicology Association Excellence in Science Award!</title>
      <description>&lt;p&gt;&lt;span data-teams="true"&gt;Congratulations to Dr. David Kirkland on receiving the 2025 Genetic Toxicology Association Excellence in Science Award!&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src="https://gta-us.org/resources/Pictures/GTA-2%20ESA%202025.png" alt="" title="" border="0"&gt;&lt;br&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13557895</link>
      <guid>https://gta-us.org/News/13557895</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Thu, 30 Oct 2025 14:31:55 GMT</pubDate>
      <title>Congratulations to Bob Young on receiving the 2025 Genetic Toxicology Association Excellence in Service Award!</title>
      <description>&lt;p&gt;&lt;span data-teams="true"&gt;Congratulations to Bob Young on receiving the 2025 Genetic Toxicology Association Excellence in Service Award!&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src="https://gta-us.org/resources/Pictures/GTA%20ESA%202025.png" alt="" title="" border="0"&gt;&lt;br&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13557893</link>
      <guid>https://gta-us.org/News/13557893</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Thu, 30 Oct 2025 14:31:11 GMT</pubDate>
      <title>Call for 2026 Excellence in Science / Service Awards (ESA) Nominations</title>
      <description>&lt;p&gt;&lt;span data-teams="true"&gt;Call for 2026 &lt;a href="https://gta-us.org/Excellence-in-Science-Award/" target="_blank"&gt;Excellence in Science / Service Awards (ESA)&lt;/a&gt; Nominations&lt;/span&gt;&lt;br&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13557890</link>
      <guid>https://gta-us.org/News/13557890</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Thu, 30 Oct 2025 14:17:30 GMT</pubDate>
      <title>MLA webinar recording now available for GTA Members!</title>
      <description>&lt;p&gt;&lt;span data-teams="true"&gt;MLA webinar recording now available for GTA Members!&lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;img src="https://gta-us.org/resources/Pictures/MLA%20Webinar.png" alt="" title="" border="0"&gt;&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;br&gt;&lt;/p&gt;

&lt;p&gt;&lt;br&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13557883</link>
      <guid>https://gta-us.org/News/13557883</guid>
      <dc:creator />
    </item>
    <item>
      <pubDate>Fri, 26 Sep 2025 18:24:37 GMT</pubDate>
      <title>Welcome to Our New Platform</title>
      <description>&lt;p data-start="2174" data-end="2429"&gt;We’re excited to announce that GTA has migrated to a modern, integrated website and membership management platform: &lt;strong data-start="2302" data-end="2317"&gt;WildApricot&lt;/strong&gt;. This upgrade marks a significant step in improving how our community interacts online and behind the scenes.&lt;/p&gt;

&lt;h3 data-start="2431" data-end="2469"&gt;&lt;strong&gt;What the New Platform Brings to You&lt;/strong&gt;&lt;/h3&gt;

&lt;table data-start="2471" data-end="3145" style=""&gt;
  &lt;thead data-start="2471" data-end="2492"&gt;
    &lt;tr data-start="2471" data-end="2492"&gt;
      &lt;th data-start="2471" data-end="2481" data-col-size="sm" align="left"&gt;Feature&lt;/th&gt;

      &lt;th style="null" width="" height="" align="left"&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&lt;/th&gt;

      &lt;th data-start="2481" data-end="2492" data-col-size="md" align="left"&gt;Benefit&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;

  &lt;tbody data-start="2503" data-end="3145"&gt;
    &lt;tr data-start="2503" data-end="2607"&gt;
      &lt;td data-start="2503" data-end="2541" data-col-size="sm"&gt;&lt;strong data-start="2505" data-end="2540"&gt;Centralized membership database&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-start="2541" data-end="2607" data-col-size="md"&gt;More accurate records, fewer duplicates, and smoother renewals&lt;/td&gt;
    &lt;/tr&gt;

    &lt;tr data-start="2608" data-end="2722"&gt;
      &lt;td data-start="2608" data-end="2640" data-col-size="sm"&gt;&lt;strong data-start="2610" data-end="2639"&gt;Enhanced event management&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-start="2640" data-end="2722" data-col-size="md"&gt;Simplified registration, seamless payments, waitlists, and automated reminders&lt;/td&gt;
    &lt;/tr&gt;

    &lt;tr data-start="2723" data-end="2839"&gt;
      &lt;td data-start="2723" data-end="2756" data-col-size="sm"&gt;&lt;strong data-start="2725" data-end="2755"&gt;Member-only content access&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-col-size="md" data-start="2756" data-end="2839"&gt;You’ll be able to log in and see exclusive resources, recordings, and documents&lt;/td&gt;
    &lt;/tr&gt;

    &lt;tr data-start="2840" data-end="2935"&gt;
      &lt;td data-start="2840" data-end="2872" data-col-size="sm"&gt;&lt;strong data-start="2842" data-end="2871"&gt;Dues automation &amp;amp; billing&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-start="2872" data-end="2935" data-col-size="md"&gt;A streamlined billing cycle and self-service payment portal&lt;/td&gt;
    &lt;/tr&gt;

    &lt;tr data-start="2936" data-end="3032"&gt;
      &lt;td data-start="2936" data-end="2968" data-col-size="sm"&gt;&lt;strong data-start="2938" data-end="2967"&gt;Mobile-friendly interface&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-start="2968" data-end="3032" data-col-size="md"&gt;Access GTA resources and events easily on phones and tablets&lt;/td&gt;
    &lt;/tr&gt;

    &lt;tr data-start="3033" data-end="3145"&gt;
      &lt;td data-start="3033" data-end="3074" data-col-size="sm"&gt;&lt;strong data-start="3035" data-end="3073"&gt;Email communications &amp;amp; newsletters&lt;/strong&gt;&lt;/td&gt;

      &lt;td style="null" width="" height="" align=""&gt;&amp;nbsp;&lt;/td&gt;

      &lt;td data-col-size="md" data-start="3074" data-end="3145"&gt;Better targeting, templates, and tracking for all GTA announcements&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;

&lt;h3 data-start="3147" data-end="3179"&gt;&lt;strong&gt;What This Means for You&lt;/strong&gt;&lt;/h3&gt;

&lt;ul data-start="3180" data-end="3637"&gt;
  &lt;li data-start="3180" data-end="3304"&gt;
    &lt;p data-start="3182" data-end="3304"&gt;If you’re a current member: look for an email with instructions on how to log into the new site and update your profile.&lt;/p&gt;
  &lt;/li&gt;

  &lt;li data-start="3305" data-end="3370"&gt;
    &lt;p data-start="3307" data-end="3370"&gt;New members will find it easier to join and get started fast.&lt;/p&gt;
  &lt;/li&gt;

  &lt;li data-start="3371" data-end="3507"&gt;
    &lt;p data-start="3373" data-end="3507"&gt;Events and meetings going forward will run on WildApricot.&lt;/p&gt;
  &lt;/li&gt;

  &lt;li data-start="3508" data-end="3637"&gt;
    &lt;p data-start="3510" data-end="3637"&gt;Our team will continue refining the site and adding features (forums, groups, resource libraries); your feedback is essential.&lt;/p&gt;
  &lt;/li&gt;
&lt;/ul&gt;

&lt;p data-start="3639" data-end="3806"&gt;We believe this new platform will help GTA become more agile, responsive, and valuable to our entire membership.&lt;/p&gt;

&lt;p data-start="3639" data-end="3806"&gt;If you have any questions, please reach out.&lt;/p&gt;

&lt;p&gt;&lt;br&gt;&lt;/p&gt;</description>
      <link>https://gta-us.org/News/13546337</link>
      <guid>https://gta-us.org/News/13546337</guid>
      <dc:creator />
    </item>
  </channel>
</rss>